(Q54771768)

3 June 2018

title

Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis. (English)

1 reference

3 June 2018

primary biliary cholangitis

main subject

liver cirrhosis

0 references

0 references

author

Gernot Zollner

1

1 reference

3 June 2018

Peter Fickert

2

1 reference

3 June 2018

Kurt Zatloukal

6

Kurt Zatloukal

1 reference

3 June 2018

Michael Trauner

8

Michael Trauner

1 reference

3 June 2018

Dagmar Silbert

3

Dagmar Silbert

1 reference

3 June 2018

Andrea Fuchsbichler

4

Andrea Fuchsbichler

1 reference

3 June 2018

Hanns-Ulrich Marschall

5

Hanns Ulrich Marschall

1 reference

3 June 2018

Helmut Denk

7

Helmut Denk

1 reference

3 June 2018

publication date

1 June 2003

1 reference

3 June 2018

published in

Journal of Hepatology

1 reference

3 June 2018

volume

38

1 reference

3 June 2018

page(s)

717-727

1 reference

3 June 2018

issue

6

1 reference

3 June 2018

cites work

Hepatobiliary transport

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

Molecular pathogenesis of cholestasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

Molecular alterations in hepatocyte transport mechanisms in acquired cholestatic liver disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

Mechanisms of cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

The expression levels of plasma membrane transporters in the cholestatic liver of patients undergoing biliary drainage and their association with the impairment of biliary secretory function

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

Expression of hepatic transporters OATP-C and MRP2 in primary sclerosing cholangitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

Expression of the hepatocyte canalicular multidrug resistance protein (MRP2) in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

Induction of multidrug resistance gene expression during cholestasis in rats and nonhuman primates.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

Up-regulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

Cellular localization and up-regulation of multidrug resistance-associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

Expression of the bile salt export pump is maintained after chronic cholestasis in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

Down-regulation of expression and function of the rat liver Na+/bile acid cotransporter in extrahepatic cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

Adaptive regulation of bile salt transporters in kidney and liver in obstructive cholestasis in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

Chronic cholestatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

Review article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

The continuing importance of bile acids in liver and intestinal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

Bile acid concentrations in human and rat liver tissue and in hepatocyte nuclei

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

The simultaneous extraction of high-molecular-weight DNA and of RNA from solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

A domain-specific marker for the hepatocyte plasma membrane: localization of leucine aminopeptidase to the bile canalicular domain

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

Regulation of the multidrug resistance protein 2 in the rat liver by lipopolysaccharide and dexamethasone.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

Induction of short heterodimer partner 1 precedes downregulation of Ntcp in bile duct-ligated mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

Ursodeoxycholic acid in primary biliary cirrhosis: no evidence for toxicity in the stages I to III.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

Clinical Approach to Jaundice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

ATP-dependent transport of bile salts by rat multidrug resistance-associated protein 3 (Mrp3)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

Transport activity of human MRP3 expressed in Sf9 cells: comparative studies with rat MRP3

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

Altered bile acid metabolism in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

Alterations in tight junctions differ between primary biliary cirrhosis and primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

Up-regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

Induction of Mdr1b expression by tumor necrosis factor-alpha in rat liver cells is independent of p53 but requires NF-kappaB signaling.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

Role of multidrug resistance 3 deficiency in pediatric and adult liver disease: one gene for three diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

Semiquantitation of intrahepatic MDR3 mRNA levels by reverse transcription/competitive polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

Bile-salt hydrophobicity is a key factor regulating rat liver plasma-membrane communication: relation to bilayer structure, fluidity and transporter expression and function

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

Abnormal expression of anion exchanger genes in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

Decreased anion exchanger 2 immunoreactivity in the liver of patients with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

Induction of rat organic anion transporting polypeptide 2 by pregnenolone-16alpha-carbonitrile is via interaction with pregnane X receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900096-5

7 January 2021

10.1016/S0168-8278(03)00096-5

Identifiers

DOI

1 reference

3 June 2018

PubMed ID

12763363

1 reference

3 June 2018